Laparoscopic sleeve gastrectomy as treatment for morbid obesity: Technique and short-term outcome

Laparoscopic sleeve gastrectomy as treatment for morbid obesity: Technique and short-term outcome
复制标题

DOI:
10.1381/096089206778663869
复制
发表时间:
2006-10-01
期刊:
影响因子:
2.9
通讯作者:
Rosenthal, Raul J.
Rosenthal, Raul J.
中科院分区:
医学3区
文献类型:
--
作者:
Roa, Paul E.;Kaidar-Person, Orit;Rosenthal, Raul J.

文献摘要

被引文献

相似文献

背景资料:腹腔镜Roux-en-Y胃旁路术(LRYGBP)和腹腔镜可调节胃束带术(LAGB)是美国最常用的减肥手术。目前,腹腔镜袖状胃切除术(LSG)正在探索中。本研究的目的是评估的安全性和短期疗效的LSG作为一种治疗选择weight reduction.Methods:数据的所有患者谁接受LSG治疗病态肥胖2004年11月至2006年3月,并完成了3个月和6个月的随访访视时的研究,进行了回顾性分析。收集的数据包括人口统计学资料,手术时间,住院时间,术后并发症,和体重reduction.Results的程度:62例患者进行LSG由两名外科医生,30例患者的数据,(7名男性和23名女性)进行了进一步分析。平均术前BMI为41.4(33-59)kg/m2。平均手术时间为80分钟(范围65-130分钟)。平均住院时间为3.2天(范围2至25天)。术后3个月和6个月的平均体重减轻分别为22.7 kg和30.5 kg,平均超额体重减轻(EWL)分别为40.7和52.8。3名患者被认为有轻度并发症,1名患者有需要手术干预的严重并发症。结论:在短期内,LSG是一种安全有效的治疗选择。
Background: Laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable gastric banding (LAGB) are the most commonly performed surgical procedures for weight reduction in the United States. Currently, laparoscopic sleeve gastrectomy (LSG) is being explored. The aim of this study was to assess the safety and short-term efficacy of LSG as a treatment option for weight reduction.Methods: Data of all patients who underwent LSG for treatment of morbid obesity between November 2004 and March 2006 and completed the 3- and 6-month follow-up visits at the time of the study, were retrospectively reviewed. Data collected included demographics, operative time, length of stay, postoperative complications, and degree of weight reduction.Results: Of the 62 patients who underwent LSG performed by two surgeons, the data of 30 patients,(7 males and 23 females) were further analyzed. Mean preoperative BMI was 41.4 (33-59) kg/m(2). Mean operative time was 80 min (range 65-130). Mean hospital stay was 3.2 days (range 2 to 25). Mean weight loss at 3 and 6 months following the procedure was 22.7 kg and 30.5 kg respectively, and mean % excess weight loss (EWL) was 40.7 and 52.8, respectively. Three patients were considered to have mild complications, and one patient had a major complication that necessitated surgical intervention. There was no mortality.Conclusions: In the short-term, LSG is a safe and effective treatment option.